Shufro Rose & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,794
| Closed | -$223K | – | 308 |
|
|
2024
Q3 | $223K | Hold |
5,794
| – | – | 0.02% | 272 |
|
|
2024
Q2 | $223K | Buy |
5,794
+630
| +12% | +$24.3K | 0.02% | 272 |
|
|
2024
Q1 | $221K | Buy |
+5,164
| New | +$221K | 0.02% | 266 |
|
|
2022
Q3 | – | Sell |
-4,854
| Closed | -$264K | – | 334 |
|
|
2022
Q2 | $264K | Buy |
+4,854
| New | +$264K | 0.02% | 237 |
|
|
2019
Q1 | – | Sell |
-7,000
| Closed | -$334K | – | 305 |
|
|
2018
Q4 | $334K | Hold |
7,000
| – | – | 0.04% | 195 |
|
|
2018
Q3 | $351K | Sell |
7,000
-720
| -9% | -$36.1K | 0.03% | 215 |
|
|
2018
Q2 | $389K | Buy |
7,720
+538
| +7% | +$27.1K | 0.04% | 195 |
|
|
2018
Q1 | $351K | Hold |
7,182
| – | – | 0.03% | 204 |
|
|
2017
Q4 | $318K | Buy |
7,182
+182
| +3% | +$8.06K | 0.03% | 213 |
|
|
2017
Q3 | $355K | Buy |
7,000
+1,200
| +21% | +$60.9K | 0.04% | 207 |
|
|
2017
Q2 | $313K | Hold |
5,800
| – | – | 0.03% | 201 |
|
|
2017
Q1 | $306K | Buy |
5,800
+600
| +12% | +$31.7K | 0.03% | 206 |
|
|
2016
Q4 | $250K | Sell |
5,200
-432
| -8% | -$20.8K | 0.03% | 218 |
|
|
2016
Q3 | $304K | Hold |
5,632
| – | – | 0.03% | 200 |
|
|
2016
Q2 | $305K | Sell |
5,632
-987
| -15% | -$53.5K | 0.03% | 192 |
|
|
2016
Q1 | $336K | Buy |
+6,619
| New | +$336K | 0.04% | 190 |
|